MedTrace Logo

Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer

NCT06396598 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 157

Last updated 2025-05-31

No results posted yet for this study

Summary

This clinical trial evaluates earlier symptom management through remote electronic symptom monitoring (such as through an app on patient's phone), and accessibility of palliative care self-referral by patients with thoracic cancer and caregivers by proxy (legal representative). Thoracic cancer occurs in the chest and often causes symptoms for patients. Patients and/or their caregivers are often unable to attend in-person clinic visits for various reasons. The most frequently reported symptom by patients at initial palliative care consultations is pain, and caregivers' most common concerns are pain management for the patient, stress reduction, and fears about patient decline. Earlier palliative care referral can help control these symptoms before they worsen, providing a better quality of life for patients and caregivers. improve physical and emotional functioning for patients and caregivers in cancer care. This study may help researchers learn how an electronic symptom monitoring program may provide an earlier and more accessible way for patients with thoracic cancer to receive palliative care.

Conditions

  • Malignant Thoracic Neoplasm

Interventions

OTHER

Educational Activity

Review education materials

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Internet-Based Intervention

Participate use the electronic symptom monitoring program to log symptoms

OTHER

Media Intervention

Watch a video

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

Principal Investigators

  • Julia L Agne, MD · Ohio State University Comprehensive Cancer Center

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-09
Primary Completion
2026-02-28
Completion
2026-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06396598 on ClinicalTrials.gov